Patent · US Active

Crystalline forms of potassium channel modulators

US11993586B2 · kind B2 · utility

0Cited by

20References

13Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Gregg F. Keaney · Lexington, US
Jun Xu · Gaithersburg, US
Wenfeng Xue · Shangrao, CN

Key dates

Filing date	Oct 21, 2019
Grant date	May 28, 2024
Priority date	—
Expiry date	Apr 22, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Provided herein are crystalline and amorphous forms of a compound having structural formula (1). Also provided are pharmaceutical compositions comprising the crystalline and amorphous forms, methods for their manufacture, and uses thereof for treating a variety of diseases, disorders or conditions, associated with potassium channels.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.